The medical simulation market is expected to reach USD 2,575.4 Million by 2022 from an estimated USD 1,284.0 Million in 2017, at a CAGR of 14.9%. The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the medical simulations market.

“By product & service, the anatomical models segment accounted for the largest share of the medical simulation market in 2016.”

On the basis of product & service, the anatomical models segment accounted for the largest share of the global medical simulation market. The large share of this segment is due to high adoption of high fidelity (degree of realism) products, increasing primary care services, and shortage of healthcare professionals.

PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1156

“North America dominated the market in 2016.”

North America accounted for the largest share of the medical simulation market in 2016, followed by Europe and Asia Pacific. High adoption of simulation by medical universities and training centers, accessibility to technologies, well-established distribution channels, and rising number of healthcare professionals demanding hands on patient training are the major factors responsible for the large share of North America in the global medical simulation market.

The prominent players in the global medical simulation market are : Laerdal Medical (Norway) and CAE (Canada) held the major share of the healthcare/medical simulation market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are 3D Systems (US), Simulab Corporation (US), Simulaids (US), Limbs and Things (UK), Kyoto Kagaku (Japan), Mentice (Sweden), Surgical Science Sweden (Sweden), and Gaumard Scientific Company (US).